Table 1 – Types of vertigo (non-exhaustive list)[/caption]
Vomiting
In older people, dizziness significantly increases the risk of falls.7 Implementing appropriate interventions to address modifiable risk factors such as dizziness is of paramount importance. In cases of drug-induced dizziness, deprescribing can be considered if the medicine can be safely reduced, discontinued or substituted to prevent inappropriate prescribing cascades of potentially inappropriate medicines (PIM), especially in the context of older people.29
A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.[/caption]
The hypothalamus houses neurons that produce neuropeptides called orexin A and B, which were discovered in 1998, and represent one of the most exciting discoveries in sleep medicine.5,13–15 Orexin-producing neurons help us stay awake and alert, especially when we really need to focus, which is critical for survival.5,14 These neurons reach out to many brain areas that use other wakefulness messengers such as acetylcholine, dopamine, histamine, serotonin and noradrenaline. These areas ‘talk back’ to the hypothalamus, to further boost wakefulness signals.5 Similarly, the thalamus is an important region that also serves to relay wakefulness signals from the RAS.5
Another dual orexin receptor antagonist (DORA), vornorexant*, is under development and currently undergoing clinical trials.28 
Other medicines such as dimdazenil* (partial positive allosteric modulator at GABAA specific to alpha-1 and alpha-5 GABAA receptor subtypes)41 and zuranolone* (positive allosteric modulator for GABAA) have also been tested, with positive outcomes in trials. Zuranolone* is marketed overseas specifically for postnatal depression, but clinical trials for its use in insomnia are ongoing.40
Kristy Carter (she/her)
Louise Edwards (she/her) Date of birth now required on all NSW scripts
From 1 November 2022, the date of birth of every patient must be included on all prescriptions for Schedule 4 and Schedule 8 medicines.
How to save a life with naloxone
By providing non-judgemental and appropriate counselling on the use of naloxone, pharmacists can empower those who carry it to confidently intervene in the case of opioid toxicity.
What pharmacists need to know about the medicinal cannabis shake up
The Australian Health Practitioner Regulation Agency (AHPRA) has cracked down on medicinal cannabis, with new guidance to tighten up the rules and put practitioners...
Efficacy and safety of diclofenac for the management of pain
Pharmacists are well equipped to assist patients who request treatment for pain. This article discusses the role of the pharmacist in the appropriate supply of over-the-counter diclofenac for management of pain.
Government pulls the plug on replica Ozempic
After much media scrutiny, the federal Department of Health and Aged Care has announced a ban on compounded GLP-1RAs.
The 6 situations when photo ID is required
Checking a patient's photo identification (ID) can be both a useful – and mandatory – practice.
Australian Pharmacist explores the instances where minimum practice and...
